Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

: An End to the Yom Kippur (and Ramadan) Headache: A Double Blind Placebo Controlled Trial of Prophylactic Rofecoxib in Preventing Ritual Fasting Headache.

NCT00263094 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT00263094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00263094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
: An End to the Yom Kippur (and Ramadan) Headache: A Double Blind Placebo Controlled Trial of Prophylactic Rofecoxib in Preventing Ritual Fasting Headache.
Lead sponsor
Sheba Medical Center
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2004
Completion date
November 30, 2004
Enrollment
220
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

headache